FR2408348A1 - (2,4-Di:oxy-6-methyl-pyrimidinyl-5-sulphonamino) di:phenyl-sulphone - used to treat skin rash caused by rheumatoid arthritis - Google Patents
(2,4-Di:oxy-6-methyl-pyrimidinyl-5-sulphonamino) di:phenyl-sulphone - used to treat skin rash caused by rheumatoid arthritisInfo
- Publication number
- FR2408348A1 FR2408348A1 FR7731896A FR7731896A FR2408348A1 FR 2408348 A1 FR2408348 A1 FR 2408348A1 FR 7731896 A FR7731896 A FR 7731896A FR 7731896 A FR7731896 A FR 7731896A FR 2408348 A1 FR2408348 A1 FR 2408348A1
- Authority
- FR
- France
- Prior art keywords
- sulphonamino
- pyrimidinyl
- methyl
- rheumatoid arthritis
- sulphone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The cpd. p.p-(2,4-dioxy-6-methyl-pyrimidinyl-5-sulphonamino)-diphenyl-sulp- hone is mixed with carrier. A tablet contains 0.1-0.2 gram of the cpd. The carrier is e.g. an injection solvent, distilled water or physiological salt soln. Used to cure red spot rash of human skin caused by rheumatoid arthritis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7731896A FR2408348B1 (en) | 1977-10-24 | 1977-10-24 | MEDICAMENT FOR THE TREATMENT OF COLLAGENOSES OF RHUMATOID ETIOLOGY, BASED ON P, P- (2,4-DIOXO-6-METHYL-PYRIMIDINYL-5-SULFONAMIDO) DIPHENYLSULFONE |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7731896A FR2408348B1 (en) | 1977-10-24 | 1977-10-24 | MEDICAMENT FOR THE TREATMENT OF COLLAGENOSES OF RHUMATOID ETIOLOGY, BASED ON P, P- (2,4-DIOXO-6-METHYL-PYRIMIDINYL-5-SULFONAMIDO) DIPHENYLSULFONE |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2408348A1 true FR2408348A1 (en) | 1979-06-08 |
FR2408348B1 FR2408348B1 (en) | 1980-06-27 |
Family
ID=9196844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7731896A Expired FR2408348B1 (en) | 1977-10-24 | 1977-10-24 | MEDICAMENT FOR THE TREATMENT OF COLLAGENOSES OF RHUMATOID ETIOLOGY, BASED ON P, P- (2,4-DIOXO-6-METHYL-PYRIMIDINYL-5-SULFONAMIDO) DIPHENYLSULFONE |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2408348B1 (en) |
-
1977
- 1977-10-24 FR FR7731896A patent/FR2408348B1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FR2408348B1 (en) | 1980-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ185000A (en) | Administering clonidine transdermally | |
FI860285A (en) | 6-TIOXANTINDERIVAT. | |
JPS53145987A (en) | Purification of polymer solution produced by microorganism | |
DE3376524D1 (en) | Skin treatment composition | |
ES8102141A1 (en) | 3,7-Disubstituted-3-cephem-4-carboxylic acid compounds | |
ZA763155B (en) | Improvements in or relating to compounds having a physiological action on the nervous system of the human body and compositions containing them | |
JPS53124627A (en) | Skin cosmetics | |
ZA787399B (en) | Medicine with activity as prostaglandin synthetase inhibitor | |
AU3502778A (en) | Skin treatment using dicarboxylic acid | |
ZA903758B (en) | Dehydrocholecalciferol derivatives | |
DE2862480D1 (en) | Use of retinoids as medicines | |
FR2408348A1 (en) | (2,4-Di:oxy-6-methyl-pyrimidinyl-5-sulphonamino) di:phenyl-sulphone - used to treat skin rash caused by rheumatoid arthritis | |
ES449597A1 (en) | 4-Imino-1,3-diazabicyclo-(3.1.0)-hexan-2-one as a cancerostat and immuno-stimulant | |
ES8304058A1 (en) | 3,7,11,15-Tetramethyl- 2,4,6,10,14-hexadecapentaenoic Acid | |
ES475050A1 (en) | Derivatives of 2,6-dipnenyl-3,7- dioxabicyclo-[3,3,0]-octane-4,8-dione | |
JPS52108991A (en) | Purification of lactam | |
JPS5417109A (en) | Production of aqueous solution for administering into vein | |
ES458413A1 (en) | Pharmaceutical composition | |
SU1607351A1 (en) | 3-BENZOIL-1-PHENYL-1N-PYRAZOLO [3,4-b] CHINOXALINE THAT IS ANTILLOUS ANTI-STATUS ACTIVITY | |
ES464780A1 (en) | Reduction of 2,5 - diketogluconic acid | |
JPS53109730A (en) | Compact pace maker | |
SU1744810A1 (en) | Vasoactive agent "dimephosphone" normalizing vegetative nervous system functions | |
JPS52130512A (en) | Pulse transmission system | |
ES413453A1 (en) | Electronic apparatus muscle neuro exerciator. (Machine-translation by Google Translate, not legally binding) | |
JPS53113081A (en) | Purification of urokinase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |